Do you like to follow institutional money flows? If so, this list may be very interesting to you.
Here we present 5 stocks that have just signaled the “Golden Cross,” a bullish momentum indicator in which the 50-day moving average crosses above the 200-day MA. These 5 stocks have also seen net institutional buying over two consecutive quarters.
Technical momentum and smart money flows are behind these names--so use this list as a starting point for your own analysis.
List sorted by market cap.
Royal Gold, Inc. (RGLD): Gold Industry. Market cap of $2.81B. SMA50 at $49.29 vs. SMA200 at $49.12 (current price at $53.10). Net institutional shares purchased during the current quarter at 376.1K and 578.8K net institutional shares purchased during the previous quarter. RGLD has a relatively low correlation to the market (beta = 0.39), which may be appealing to risk-averse investors. The stock has gained 5.27% over the last year.
Healthcare Realty Trust Inc. (HR): REIT Industry. Market cap of $1.58B. SMA50 at $22.03 vs. SMA200 at $21.97 (current price at $22.79). Net institutional shares purchased during the current quarter at 2.4M and 867.2K net institutional shares purchased during the previous quarter. The stock is a short squeeze candidate, with a short float at 7.35% (equivalent to 8.18 days of average volume). The stock has lost 0.18% over the last year.
Harry Winston Diamond Corporation (HWD): Nonmetallic Mineral Mining Industry. Market cap of $1.42B. SMA50 at $13.00 vs. SMA200 at $12.43 (current price at $17.58). Net institutional shares purchased during the current quarter at 298.8K and 12.1M net institutional shares purchased during the previous quarter. The stock has had a couple of great days, gaining 16.78% over the last week.
RTI International Metals, Inc. (RTI): Industrial Metals & Minerals Industry. Market cap of $939.49M. SMA50 at $28.56 vs. SMA200 at $28.22 (current price at $32.08). Net institutional shares purchased during the current quarter at 279.6K and 65.3K net institutional shares purchased during the previous quarter. Short float at 9.99% (equivalent to 6.12 days of average volume), indicating the stock is a short squeeze candidate. The stock has gained 2.37% over the last year.
Cadence Pharmaceuticals Inc. (CADX): Biotechnology Industry. Market cap of $596.77M. SMA50 at $8.11 vs. SMA200 at $7.92 (current price at $9.54). Net institutional shares purchased during the current quarter at 16.6M and 727.1K net institutional shares purchased during the previous quarter. The stock is a short squeeze candidate, with a short float at 23.88% (equivalent to 34.75 days of average volume). The stock has lost 2.68% over the last year.
Institutional data sourced from Fidelity, all other data sourced from Finviz.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
